- Home
- TCPC vs IRMD Comparison
TCPC vs IRMD Comparison
Compare TCPC & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCPC
- IRMD
- Stock Information
- Founded
- TCPC 2006
- IRMD 1992
- Country
- TCPC United States
- IRMD United States
- Employees
- TCPC N/A
- IRMD N/A
- Industry
- TCPC Finance/Investors Services
- IRMD Medical/Dental Instruments
- Sector
- TCPC Finance
- IRMD Health Care
- Exchange
- TCPC Nasdaq
- IRMD Nasdaq
- Market Cap
- TCPC 665.8M
- IRMD 668.2M
- IPO Year
- TCPC 2012
- IRMD 2014
- Fundamental
- Price
- TCPC $7.57
- IRMD $58.24
- Analyst Decision
- TCPC Hold
- IRMD Strong Buy
- Analyst Count
- TCPC 4
- IRMD 1
- Target Price
- TCPC $7.50
- IRMD $72.00
- AVG Volume (30 Days)
- TCPC 472.7K
- IRMD 48.5K
- Earning Date
- TCPC 08-06-2025
- IRMD 07-31-2025
- Dividend Yield
- TCPC 18.04%
- IRMD 1.18%
- EPS Growth
- TCPC N/A
- IRMD 10.72
- EPS
- TCPC N/A
- IRMD 1.55
- Revenue
- TCPC $259,596,996.00
- IRMD $75,154,639.00
- Revenue This Year
- TCPC N/A
- IRMD $10.62
- Revenue Next Year
- TCPC N/A
- IRMD $9.69
- P/E Ratio
- TCPC N/A
- IRMD $37.23
- Revenue Growth
- TCPC 20.88
- IRMD 11.04
- 52 Week Low
- TCPC $6.27
- IRMD $42.11
- 52 Week High
- TCPC $11.06
- IRMD $63.29
- Technical
- Relative Strength Index (RSI)
- TCPC 48.34
- IRMD 55.66
- Support Level
- TCPC $7.21
- IRMD $57.66
- Resistance Level
- TCPC $7.97
- IRMD $59.91
- Average True Range (ATR)
- TCPC 0.17
- IRMD 1.71
- MACD
- TCPC -0.06
- IRMD -0.29
- Stochastic Oscillator
- TCPC 42.35
- IRMD 44.82
About TCPC BlackRock TCP Capital Corp.
BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.